Advanced search
Publication Cover
Renal Failure Volume 42, 2020 - Issue 1
Submit an article Journal homepage
2,113
Views
8
CrossRef citations to date
0
Altmetric
Clinical Study

Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure

Yaqi ChengDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Jin ShangDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Dong LiuDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
,
Jing XiaoDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
&
Zhanzheng ZhaoDepartment of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
View further author information
Pages 550-559 | Received 29 Jan 2020, Accepted 11 May 2020, Published online: 11 Jun 2020

References

  • Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37(10):2864–2883.
  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.
  • Collins AJ, Foley RN, Chavers B, et al. US renal data system 2013 annual data report. Am J Kidney Dis. 2014;63(1):A7.
  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey.Lancet. 2012;379(9818):815–822.
  • Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–1559.
  • Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–174.
  • Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018.
  • American Diabetes Association. Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes. 2017;35(1):5–26.
  • Doshi SM, Friedman AN. Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol. 2017;12(8):1366–1373.
  • Wan EYF, Fong DYT, Fung CSC, et al. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study. BMC Nephrol. 2017;18(1):257.
  • Dunkler D, Gao P, Lee SF, et al. Risk prediction for early CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10(8):1371–1379.
  • Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl. 2018;8(1):2–7.
  • Buuren SV, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Soft. 2011;45(3):1–67.
  • Zhang Y, Yang Y. Cross-validation for selecting a model selection procedure. J Econom. 2015;187(1):95–112.
  • Jung Y. Multiple predicting K-fold cross-validation for model selection. J Nonparametr Stat. 2018;30(1):197–215.
  • Jardine MJ, Hata J, Woodward M, et al. Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis. 2012;60(5):770–778.
  • Chien KL, Lin HJ, Lee BC, et al. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123(9):836–846.
  • Lennartz CS, Pickering JW, Seiler-Mussler S, et al. External validation of the kidney failure risk equation and re-calibration with addition of ultrasound parameters. CJASN. 2016;11(4):609–615.
  • Chen PM, Wada T, Chiang CK. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience. Clin Exp Nephrol. 2017;21(2):307–315.
  • Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetologia. 2018;61(5):996–1011.
  • Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. CJASN. 2010;5(6):1003–1009.
  • Haynes R, Staplin N, Emberson J, et al. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2014;64(1):40–48.
  • Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–232.
  • Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002;61(4):1453–1461.
  • Pucci L, Triscornia S, Lucchesi D, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53(3):480–488.
  • Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab. 2008;34(5):482–489.
  • Afsar B. The relationship between neutrophil lymphocyte ratio with urinary protein and albumin excretion in newly diagnosed patients with type 2 diabetes. Am J Med Sci. 2014;347(3):217–220.
  • Wheelock KM, Saulnier PJ, Tanamas SK, et al. White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes. Nephrol Dial Transplant. 2018;33(6):1001–1009.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.